Digital Therapeutics Innovator The Learning Corp Adds Dr. Shaheen Lakhan as VP of Research and Development

NEWTON, Mass.--(BUSINESS WIRE)-- The Learning Corp, a leader in digital therapeutics and makers of mobile therapy platform Constant Therapy, today announced that Shaheen Lakhan, MD, PhD, MEd, MS, has joined the company as Vice President of Research and Development.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191001005200/en/

Dr. Shaheen Lakhan has joined digital therapeutics leader The Learning Corp as Vice President of Research & Development. (Photo: Business Wire)

An award-winning physician-scientist and clinical development specialist, Dr. Lakhan is board-certified in both neurology and pain medicine with clinical training from the Cleveland Clinic and Massachusetts General Hospital. He has served on the faculty of leading institutions including Harvard Medical School and Case Western Reserve University, and as founding neurology department chair at California University of Science and Medicine. In his most recent position, Dr. Lakhan advanced neuroscience drug discovery, development and delivery as medical director at Sage Therapeutics in Cambridge, Mass.

“We are thrilled to welcome Dr. Lakhan to The Learning Corp team as we continue our mission to advance brain health via breakthrough technology,” said Michael Evers, Chief Executive Officer at The Learning Corp. “I am confident that Dr. Lakhan’s expertise will benefit our tens of thousands of current and future users as he helps us bring the next generation of digital therapeutics to the market.”

In his new role at The Learning Corp, Dr. Lakhan will lead discovery, preclinical and clinical development and operations, and regulatory affairs. He will oversee research for the company - which is home to one of the world’s largest brain rehabilitation databases - as head of the science team, whose current areas of investigation include stroke, traumatic brain injury and neurological disorders such as aphasia, Alzheimer’s disease and other forms of dementia, multiple sclerosis, Parkinson’s and developmental disorders.

“There is an incredible amount of unmet need for neurological patients, and harnessing tech to bridge those gaps in care by creating clinically proven, non-invasive solutions is powerful,” said Dr. Lakhan. “Joining The Learning Corp offers me a unique opportunity to leverage my medical, scientific, and drug development experiences to develop the most innovative, best-in-class digital therapeutics that promote brain health.”

In addition to his clinical service and academic appointments, Dr. Lakhan is a noted neuroscience researcher and advocate. In 2017, he was recognized by his peers and inducted as Fellow of the American Academy of Neurology, the institution’s highest designation. He was bestowed the Harvard Medical School Dean’s Community Service Award for founding the Global Neuroscience Initiative Foundation. He was also conferred the President’s Call to Service Award for Lifetime Achievement by Pres. George W. Bush and The U.S. Congressional Award Gold Medal by Sen. Nancy Pelosi and Sen. Harry Reid.

About The Learning Corp
The Learning Corp is a leading digital therapeutics company that combines AI and real-world evidence to deliver next-generation health and wellness products. The company created Constant Therapy, an app that gives people with brain injuries or cognitive disorders direct access to clinically proven exercises that can help them rebuild their cognitive and speech functions. Developed by a team of top neuroscientists and clinicians at Boston University, Constant Therapy is used by tens of thousands of patients, whose experience is informing the company’s clinical products and creating the insights that can lead to new discoveries for brain health. For more information, visit thelearningcorp.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191001005200/en/